Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines
Clinical trial NCT03308825 · COMPLETED
Trial details
- NCT number
- NCT03308825
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-11
- Primary completion
- 2017-11-22
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.